Prevalence of Obesity and Its Influence on Achievement of Cardiometabolic Therapeutic Goals in Chinese Type 2 Diabetes Patients: An Analysis of the Nationwide, Cross-Sectional 3B Study

• Xianghai Zhou,

  Affiliations Department of Endocrinology and Metabolism, Peking University People’s Hospital, Beijing, China, Peking University Diabetes Center, Beijing, China

  ⨯
• Linong Ji ,

  * E-mail: jiln@bjmu.edu.cn

  Affiliations Department of Endocrinology and Metabolism, Peking University People’s Hospital, Beijing, China, Peking University Diabetes Center, Beijing, China

  ⨯
• Xingwu Ran,

  Affiliation Department of Endocrinology & Metabolism, West China Hospital, Sichuan University, Chengdu, China

  ⨯
• Benli Su,

  Affiliation Department of Endocrinology & Metabolism, The Second Affiliated Hospital of Dalian Medical University, Dalian, China

  ⨯
• Qiuhe Ji,

  Affiliation Department of Endocrinology, Xijing Hospital, Forth Military Medical University, Xi’an, China

  ⨯
• Changyu Pan,

  Affiliation Department of Endocrinology, Chinese PLA General Hospital, Beijing, China

  ⨯
• Jianping Weng,

  Affiliation Department of Endocrinology and Metabolism, The Third Affiliated Hospital Sun Yat-sen University, Guangzhou, China

  ⨯
• Changsheng Ma,

  Affiliation Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China

  ⨯
• Chuanming Hao,

  Affiliation Division of Nephrology, Huashan Hospital, Fudan University, Shanghai, China

  ⨯
• Danyi Zhang,

  Affiliation Vital Strategic Research Institute, Berwyn, Pennsylvania, United States of America

  ⨯
• Dayi Hu,

  Affiliation Department of Cardiology, Peking University People’s Hospital, Beijing, China

  ⨯
• CCMR Advisory Board and CCMR-3B Study Investigators

  ¶Membership of the CCMR Advisory Board and CCMR-3B Investigators is provided in S1 Appendix.

  ⨯